Project Management for the Biotechnology Industry

The biotech industry is a challenging business. Long lead times, high development expenses and high failure rates of projects are facts of life. An ever-changing market environment contributes to the uncertainties. In this book the author Johanna Holldack presents an approach for using project management in the biotech industry. The book elucidates the methodology and the organization. It describes, how a detailed development plan can be compiled. It explains, how sound detailed development strategies for each and every project are one of the prerequisites for a realistic budget, business and portfolio strategy and can improve the overall performance of the company. This book provides an introduction to project management in biotech companies for everybody interested in the development, management and evaluation of projects and companies. This includes, but is not limited to: project managers, supervisors of project managers, functional managers and project team members, financial and business development personal, management of biotech companies, analysts, investors and people, who consider to join the biotech industry.
Johanna Holldack MD, has an international track record in drug development, project and portfolio management, organisational design, budgeting, strategic planning, licensing, M&A, fund raising and IPO. She held positions as Vice President for Project Management at Chiron Corp. in Emeryville, USA, Chief Operating Officer at MediGene in Munich, Germany and is currently Chief Executive Officer at Borean Pharma in Aarhus, Denmark.